A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. 1989

J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico

In this sample of moderately to severely depressed outpatients, nefazodone therapy proved superior to placebo. Nefazodone therapy was also associated with fewer dropouts from adverse effects than was imipramine. In view of these efficacy findings as well as the promising side effect and safety profile of nefazodone, further research is warranted to evaluate its therapeutic potential in the treatment of depressive illness.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
June 1994, The Journal of clinical psychiatry,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
June 1994, The British journal of psychiatry : the journal of mental science,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
January 1996, The Journal of clinical psychiatry,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
January 1996, The Journal of clinical psychiatry,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
August 1982, Acta psychiatrica Scandinavica,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
June 1996, The British journal of psychiatry : the journal of mental science,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
January 1989, Acta psychiatrica Scandinavica. Supplementum,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
February 1992, The Journal of clinical psychiatry,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
April 1989, International clinical psychopharmacology,
J P Feighner, and R Pambakian, and R C Fowler, and W F Boyer, and M F D'Amico
February 1992, The Journal of clinical psychiatry,
Copied contents to your clipboard!